Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer improved long-term ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer (NSCLC) - the ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

As Cheryl Cioffi graduated from high school and prepared for the next phase of her life, she didn’t think about a career in health care. Cioffi has lived in County most of her life and began working ...

CARE Hospitals is proud to welcome Dr. Nagireddi Nageswara Rao, a distinguished Clinical Director & Senior Consultant – ...

In talks at the annual meeting of the American Society of Clinical Oncology (ASCO), experts from Roswell Park Comprehensive Cancer Center will give remarks on racial and ethnic disparities in outcomes ...

Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer.

Patients with stage II and IIIB non-small cell lung cancer (NSCLC) with an EGFR mutation had better outcomes when treated ...

An ASCO session on quality services shows how patient and caregiver engagement is crucial to gain better outcomes and cost ...

Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not ...